Pharmafile Logo
Pharmafocus logo
Advanced Search
Merck logo

Merck and Advaxis team up on immuno-oncology

August 26, 2014
Manufacturing and Production, Medical Communications, Research and Development ASCO, Merck, immunology, pd-1, pembrolizumab

Advaxis and Merck have signed a research deal to investigational Merck’s PD-1 inhibitor pembrolizumab in combination with Advaxis’ listeria-based cancer …

News
nricciardi_asterias

Asterias Biotherapeutics adds two to board

August 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asterias Biotherapeutics, Pfizer

US biotech firm Asterias Biotherapeutics has confirmed the appointments of Andrew Arno and Natale Ricciardi to its board of directors. …

Appointment

NICE and market access: time for reform?

August 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bristol-Myers Squibb, NICE, Yervoy, reform

Earlier in the year, at the ABPI’s annual conference, the UK pharma lobby group released a new report suggesting that …

Feature
roche_glass_building

Roche pays $8.3bn for InterMune

August 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Genentech, IPF, Illumina, InterMune, Roche

Roche has stumped up $8.3 billion in cash to pay for US biotech firm InterMune and will gain access to …

News
eliquis image

Pfizer/BMS blood thinner gains new licence

August 22, 2014
Sales and Marketing BMS, DVT, Eliquis, Pfizer, Pradaxa, Xarelto, blood, warfarin

Pfizer and Bristol-Myers Squibb have been handed a much-needed lift after its new blood thinner Eliquis gained a licence extension …

News
Astrazeneca image

AstraZeneca shores up defences against Pfizer

August 22, 2014
Medical Communications, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, deal, merger

AstraZeneca has been making a series of big deals over the past three months as it looks to close the …

News
dr-siddharth-chachad

ELC Group names new senior head

August 22, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Siddharth Chachad, elf group

UK regulatory affairs provider the ELC Group has confirmed the appointment of clinical pharmacologist Dr Siddharth Chachad as its head …

Appointment

Wellcome Trust makes Ebola research investment

August 21, 2014
Research and Development, Sales and Marketing Africa, Ebola, Nigeria, deltas, welcome trust

The Wellcome Trust is launching a new multimillion pound initiative for emergency Ebola research coupled with a £40 million investment …

News
Paula Deen image

Celebrity-endorsed drug ads don’t work, says research

August 21, 2014
Medical Communications, Sales and Marketing advertising, bon jovi, dtc, healthcare marketing, paula deen, pharma

New research reveals the US system of using celebrity-endorsed drug adverts offer treatments more credibility but not influence when it …

News
warren_crawford

Masters Speciality Pharma hires head from Idis

August 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing masters speciality pharma, warren crawford

Masters Speciality Pharma has appointed Warren Crawford as a partner development director to lead and implement creative deal structures for …

Appointment

GPs admit to wrongly prescribing antibiotics

August 20, 2014
Medical Communications, Sales and Marketing GPs, UK, doctors, longitude, prescribing, prize

Nearly half of British GPs surveyed have admitted to prescribing antibiotics unnecessarily due to uncertainty and a lack of diagnostic …

News
AstraZeneca image

AZ and Mitsubishi partner on diabetic nephropathy

August 20, 2014
Research and Development, Sales and Marketing AstraZeneca, BMS, Mitsubishi, cvmd, diabetes, nephropathy

AstraZeneca and Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) have signed a new three-year research deal in the area of …

News
Sanofi image

FDA approves Sanofi’s new rare disease drug

August 20, 2014
Research and Development, Sales and Marketing Elelyso, Gaucher disease, Genzyme, Sanofi, eliglustat

Sanofi’s biologics unit Genzyme has been granted approval for a new drug to treat the rare genetic disorder Gaucher’s disease. …

News
screen_shot_2014-08-20_at_08

New chief executive for Rabin Martin

August 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing jeffrey sturchio, rabin martin

US health consulting firm Rabin Martin has appointed Dr Jeffrey Sturchio as its new president and chief executive. Sturchio joined …

Appointment
Brilinta image

Reprieve for AstraZeneca as US drops drug investigation

August 19, 2014
Sales and Marketing AstraZeneca, Brilinta, US, blood, justice, plato

The US Justice Department has pulled a controversial investigation into AstraZeneca’s pivotal clinical trial after finding no wrongdoing. The inquiry …

News
Sanofi image

Sanofi and PATH launch large-scale malaria drug production

August 19, 2014
Manufacturing and Production, Sales and Marketing Africa, Sanofi, acts, artemisinin, malaria, path

Sanofi and global health charity PATH have come together to launch a large-scale production line of malaria jab semisynthetic artemisinin …

News
miles_snowden

New chief medical officer for TeamHealth

August 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing miles, snowden, teamhealth

Outsourced doctor staffing US firm TeamHealth Holdings has appointed Dr Miles Snowden as the company’s chief medical officer (CMO). Snowden …

Appointment
Freeman image

Science will ‘lose out’ if Scotland chooses independence

August 18, 2014
Research and Development, Sales and Marketing Conservative, Scotland, UK, george freeman, life sciences

The new minister for UK life sciences George Freeman has warned that independence from England “would damage Scotland’s edge in …

News
cancer image

Top four cancer killer rates ‘fall by a third’

August 18, 2014
Research and Development, Sales and Marketing CRUK, Cancer, bowel, charity, lung, prostate, research

Death rates for breast, bowel, lung and prostate cancer combined have fallen by almost a third in the last 20 …

News
Biogen image

FDA approves Biogen’s long-acting MS drug

August 18, 2014
Sales and Marketing Avonex, Biogen, FDA, MS, Rebif, plegridy, tecfidera

Biogen Idec has racked up another approval over the weekend after its latest multiple sclerosis treatment Plegridy gained FDA backing. …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026